Maximizing Investigators' Research Award (R35)

最大化研究者研究奖(R35)

基本信息

  • 批准号:
    10630947
  • 负责人:
  • 金额:
    $ 41.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-01 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The “Tools for Transmission of Agents and Conditions (TRAC)” program will synergize statistical and mathematical modeling work in three areas of application: 1) Tuberculosis (TB) incidence and transmission; 2) monitoring substance use disorder (SUD) patterns; and 3) SARS CoV-2 transmission modeling. These three conditions are major public health problems, with TB being the leading cause of infectious disease death globally, SUD causing more deaths in the United States than HIV/AIDS in its peak, and SARS CoV-2 causing a pandemic with societal disruption and mortality exceeding anything we have experienced in the last century. We need improved analytical tools that leverage existing data to monitor these diseases, infer transmission hot spots, determine the efficacy of interventions, and understand the burden of these conditions. This program will bring together an expert group of quantitative researchers with skills that are readily applied to these problems. We also leverage our strong collaborations with clinician researchers and public health officials to ensure that the methods we develop are addressing important questions and consistent with our current understanding of these diseases. By creating a program to facilitate communication between these experts, we will enable greater innovation in modeling key aspects of these diseases and create exciting methodological synergies across diseases. Our team is well positioned to incorporate data from emerging technologies, including high throughput sequencing data to determine TB risk signatures and inform transmission links for TB and SARS CoV-2. Our expertise in machine learning, a broad range of statistical methodologies, and mathematical modeling will enable us to leverage the rich information in large databases that are emerging to better understand SUD patterns and identify risk signatures. We will also build infrastructure with our partners to make the analytical tools that we develop more accessible to public health practitioners and other researchers. The impact of this work is to develop a suite of analytical tools that leverage rapidly emerging rich data sets to improve our understanding of disease transmission patterns, monitor changing dynamics of these conditions, and understand intervention strategies that are most effective. This work will inform public health practice for these diseases and create reproducible tools that can be used in an ongoing way.
项目总结

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion.
抗体逃逸,血清型形成的风险和快速免疫减弱:建模SARS-COV-2免疫逃避的含义。
  • DOI:
    10.1371/journal.pone.0292099
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
  • 通讯作者:
Reproducible Science Is Vital for a Stronger Evidence Base During the COVID-19 Pandemic.
在 COVID-19 大流行期间,可重复的科学对于建立更强有力的证据基础至关重要。
  • DOI:
    10.1111/gean.12314
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.6
  • 作者:
    Sy,KarlaThereseL;White,LauraF;Nichols,BrookeE
  • 通讯作者:
    Nichols,BrookeE
Heterogeneity in Vaccinal Immunity to SARS-CoV-2 Can Be Addressed by a Personalized Booster Strategy.
  • DOI:
    10.3390/vaccines11040806
  • 发表时间:
    2023-04-06
  • 期刊:
  • 影响因子:
    7.8
  • 作者:
    Stoddard M;Yuan L;Sarkar S;Mangalaganesh S;Nolan RP;Bottino D;Hather G;Hochberg NS;White LF;Chakravarty A
  • 通讯作者:
    Chakravarty A
Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2.
  • DOI:
    10.1371/journal.pone.0254734
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Stoddard M;Sarkar S;Yuan L;Nolan RP;White DE;White LF;Hochberg NS;Chakravarty A
  • 通讯作者:
    Chakravarty A
Estimation of local time-varying reproduction numbers in noisy surveillance data.
噪声监视数据中局部时变繁殖数的估计。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura Forsberg White其他文献

The choice of the number of bins for the <math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si42.gif" display="inline" overflow="scroll" class="math"><mi>M</mi></math> statistic
  • DOI:
    10.1016/j.csda.2009.03.005
  • 发表时间:
    2009-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Laura Forsberg White;Marco Bonetti;Marcello Pagano
  • 通讯作者:
    Marcello Pagano

Laura Forsberg White的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura Forsberg White', 18)}}的其他基金

Maximizing Investigators' Research Award (R35)
最大化研究者研究奖(R35)
  • 批准号:
    10205596
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Maximizing Investigators' Research Award (R35)
最大化研究者研究奖(R35)
  • 批准号:
    10406164
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis
评估干预措施对结核病发病率和传播效果的方法
  • 批准号:
    9284814
  • 财政年份:
    2017
  • 资助金额:
    $ 41.25万
  • 项目类别:
Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis
评估干预措施对结核病发病率和传播效果的方法
  • 批准号:
    9884778
  • 财政年份:
    2017
  • 资助金额:
    $ 41.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了